Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IMAB

12 Health Care Stocks Moving In Monday's Intraday Session

50 Stocks Moving In Wednesday's Mid-Day Session

50 Stocks Moving In Wednesday's Mid-Day Session

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

53 Biggest Movers From Yesterday

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum Co. for a digital solution to manage Marine Logistics.

Mid-Afternoon Market Update: Dow Jumps Around 300 Points; AlloVir Shares Spike Higher

U.S. stocks traded mixed toward the end of trading, with the Dow Jones climbing around 300 points on Wednesday.

28 Stocks Moving In Wednesday's Mid-Day Session

Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday.

10 Biggest Price Target Changes For Wednesday

Morgan Stanley raised the price target on IGM Biosciences, Inc. (NASDAQ: IGMS) from $25 to $30. IGM Biosciences shares fell 4% to $28.32 in pre-market trading.

inkl

Read news from The Economist, FT, and more,
with one subscription

I-MAB FY 2021 Earnings Conference Call On March 29, 2022 At 08:00 AM ET

I-MAB FY 2021 Earnings Conference Call On March 29, 2022 At 08:00 AM ET

I-MAB (NASDAQ:IMAB) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss FY 2021 earnings results.

Why I-Mab Shares Are Jumping Today

Why I-Mab Shares Are Jumping Today

I-Mab (NASDAQ: IMAB) has provided updates on the recent development relating to the Holding Foreign Companies Accountable Act (HFCAA) and its implementation. I-Mab is not on this list, and it has taken proactive measures in response.

Organisations

CASI Pharmaceuticals

Mirati rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

264,884 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play